TrialJournal of neuro-oncology2010
Salvage therapy with single agent bevacizumab for recurrent glioblastoma.
Marc C Chamberlain et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled ittrialcites it